Paul Tudor Jones Jazz Pharmaceuticals PLC Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 25,702 shares of JAZZ stock, worth $2.74 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,702
Previous 32,958
22.02%
Holding current value
$2.74 Million
Previous $4.05 Million
23.64%
% of portfolio
0.02%
Previous 0.03%
Shares
24 transactions
Others Institutions Holding JAZZ
# of Institutions
514Shares Held
57.1MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$755 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$688 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$263 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$254 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$160 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.69B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...